Sorenson, Corinna, Naci, Huseyin, Cylus, Jonathan and Mossialos, Elias (2011) Evidence of comparative efficacy should have a formal role in European drug approvals. British medical journal, 343 (7822). d4849-d4849. ISSN 0959-8138
|
PDF
Download (299Kb) | Preview |
Abstract
Despite methodological concerns, comparative efficacy evidence should be required at the time of drug approval, says Corinna Sorenson and colleagues, to allow patients, clinicians, and other healthcare decision makers to determine whether a new drug is superior, equivalent, or inferior to its existing alternatives.
| Item Type: | Article |
|---|---|
| Official URL: | http://www.bmj.com/ |
| Additional Information: | © 2011 BMJ Publishing Group |
| Library of Congress subject classification: | R Medicine > RA Public aspects of medicine R Medicine > RM Therapeutics. Pharmacology |
| Sets: | Departments > Social Policy Research centres and groups > LSE Health |
| Rights: | http://www.lse.ac.uk/library/rights/LSERO.htm |
| URL: | http://eprints.lse.ac.uk/38191/ |
Actions (login required)
 |
Record administration - authorised staff only |
